284 related articles for article (PubMed ID: 24134704)
1. Association of BK viremia with human leukocyte antigen mismatches and acute rejection, but not with type of calcineurin inhibitor.
Hässig A; Roos M; Etter A; Bossart W; Müller N; Schiesser M; Wüthrich RP; Fehr T
Transpl Infect Dis; 2014 Feb; 16(1):44-54. PubMed ID: 24134704
[TBL] [Abstract][Full Text] [Related]
2. Screening for BK viremia reduces but does not eliminate the risk of BK nephropathy: a single-center retrospective analysis.
Knight RJ; Gaber LW; Patel SJ; DeVos JM; Moore LW; Gaber AO
Transplantation; 2013 Apr; 95(7):949-54. PubMed ID: 23545506
[TBL] [Abstract][Full Text] [Related]
3. BK viremia surveillance after kidney transplant: single-center experience during a change from cyclosporine-to lower-dose tacrolimus-based primary immunosuppression regimen.
Geddes CC; Gunson R; Mazonakis E; Wan R; Thomson L; Clancy M; Carman WF
Transpl Infect Dis; 2011 Apr; 13(2):109-16. PubMed ID: 21457419
[TBL] [Abstract][Full Text] [Related]
4. Association of treatment with 15-deoxyspergualin and BK virus nephropathy in kidney allograft recipients.
Shi Y; Moriyama T; Namba Y; Yamanaka M; Hanafuse T; Imamura R; Ichimaru N; Oka K; Kyo M; Tian Y; Takahara S; Ichikawa S; Okuyama A
Clin Transplant; 2007; 21(4):502-9. PubMed ID: 17645710
[TBL] [Abstract][Full Text] [Related]
5. BK virus viremia in a well-HLA-matched kidney transplant population mainly on low-dose cyclosporine-based immunosuppression.
Helanterä I; Salmela K; Kyllönen L; Räisänen-Sokolowski A; Auvinen E; Mannonen L; Koskinen P; Lautenschlager I
Clin Transplant; 2012; 26(6):E596-601. PubMed ID: 23083418
[TBL] [Abstract][Full Text] [Related]
6. Onset and progression of de novo donor-specific anti-human leukocyte antigen antibodies after BK polyomavirus and preemptive immunosuppression reduction.
Dieplinger G; Everly MJ; Briley KP; Haisch CE; Bolin P; Maldonado AQ; Kendrick WT; Kendrick SA; Morgan C; Terasaki PI; Rebellato LM
Transpl Infect Dis; 2015 Dec; 17(6):848-58. PubMed ID: 26442607
[TBL] [Abstract][Full Text] [Related]
7. Monitoring of polyomavirus BK replication and impact of preemptive immunosuppression reduction in renal-transplant recipients in China: a 5-year single-center analysis.
Huang G; Wang CX; Zhang L; Fei JG; Deng SX; Qiu J; Li J; Chen GD; Fu Q; Chen LZ
Diagn Microbiol Infect Dis; 2015 Jan; 81(1):21-6. PubMed ID: 25445121
[TBL] [Abstract][Full Text] [Related]
8. Incidence of BK polyomavirus infection after kidney transplantation is independent of type of immunosuppressive therapy.
Radtke J; Dietze N; Fischer L; Achilles EG; Li J; Scheidat S; Thaiss F; Nashan B; Koch M
Transpl Infect Dis; 2016 Dec; 18(6):850-855. PubMed ID: 27639176
[TBL] [Abstract][Full Text] [Related]
9. The risk of polyomavirus-associated graft nephropathy is increased by a combined suppression of CD8 and CD4 cell-dependent immune effects.
Renner FC; Dietrich H; Bulut N; Celik D; Freitag E; Gaertner N; Karoui S; Mark J; Raatz C; Weimer R; Feustel A
Transplant Proc; 2013 May; 45(4):1608-10. PubMed ID: 23726630
[TBL] [Abstract][Full Text] [Related]
10. BK viremia surveillance and outcomes in simultaneous pancreas-kidney transplant recipients.
Westphal SG; Lyden ER; Langewisch ED; Miles CD
Clin Transplant; 2017 Aug; 31(8):. PubMed ID: 28509373
[TBL] [Abstract][Full Text] [Related]
11. Active management versus minimization of immunosuppressives of BK virus-associated nephropathy after a kidney transplant.
Halim MA; Al-Otaibi T; Gheith O; Zkaria Z; Mosaad A; Said T; Nair P; Nampoory N
Exp Clin Transplant; 2014 Dec; 12(6):528-33. PubMed ID: 25489803
[TBL] [Abstract][Full Text] [Related]
12. Conversion from tacrolimus-mycophenolate mofetil to tacrolimus-mTOR immunosuppression after kidney-pancreas transplantation reduces the incidence of both BK and CMV viremia.
Knight RJ; Graviss EA; Nguyen DT; Kuten SA; Patel SJ; Gaber L; Gaber AO
Clin Transplant; 2018 Jun; 32(6):e13265. PubMed ID: 29676018
[TBL] [Abstract][Full Text] [Related]
13. Long-Term Follow-Up of Active Treatment Versus Minimization of Immunosuppressive Agents in Patients With BK Virus-Associated Nephropathy After Kidney Transplant.
Halim MA; Al-Otaibi T; Gheith O; Mosaad A; Zakaria Z; Said T; Nair P; Nampoory NM
Exp Clin Transplant; 2016 Feb; 14(1):58-65. PubMed ID: 26862825
[TBL] [Abstract][Full Text] [Related]
14. Association of BKV viremia and nephropathy with adverse alloimmune outcomes in kidney transplant recipients.
Rampersad C; Wiebe C; Balshaw R; Bullard J; Gibson IW; Trachtenberg A; Shaw J; Villalobos APC; Karpinski M; Goldberg A; Birk P; Pinsk M; Rush DN; Nickerson PW; Ho J
Clin Transplant; 2024 May; 38(5):e15329. PubMed ID: 38722085
[TBL] [Abstract][Full Text] [Related]
15. Preemptive reduction of immunosuppression upon high urinary polyomavirus loads improves patient survival without affecting kidney graft function.
Broeders EN; Hamade A; El Mountahi F; Racapé J; Hougardy JM; Le Moine A; Vereerstraeten P
Transpl Infect Dis; 2016 Dec; 18(6):872-880. PubMed ID: 27615506
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of BK viremia using reduction in immunosuppression without antiviral therapy.
Saad ER; Bresnahan BA; Cohen EP; Lu N; Orentas RJ; Vasudev B; Hariharan S
Transplantation; 2008 Mar; 85(6):850-4. PubMed ID: 18360267
[TBL] [Abstract][Full Text] [Related]
17. Conversion to a sirolimus-based regimen is associated with lower incidence of BK viremia in low-risk kidney transplant recipients.
Tohme FA; Kalil RS; Thomas CP
Transpl Infect Dis; 2015 Feb; 17(1):66-72. PubMed ID: 25582442
[TBL] [Abstract][Full Text] [Related]
18. Polyomavirus Reactivation and Immune Responses to Kidney-Specific Self-Antigens in Transplantation.
Seifert ME; Gunasekaran M; Horwedel TA; Daloul R; Storch GA; Mohanakumar T; Brennan DC
J Am Soc Nephrol; 2017 Apr; 28(4):1314-1325. PubMed ID: 27821629
[TBL] [Abstract][Full Text] [Related]
19. Increased BK viremia and progression to BK-virus nephropathy following high-dose intravenous immunoglobulin for acute cellular rejection.
Boonyapredee M; Knight K; Little D
Mil Med; 2014 Jun; 179(6):e699-702. PubMed ID: 24902140
[TBL] [Abstract][Full Text] [Related]
20. The impact of surveillance and rapid reduction in immunosuppression to control BK virus-related graft injury in kidney transplantation.
Elfadawy N; Flechner SM; Liu X; Schold J; Tian D; Srinivas TR; Poggio E; Fatica R; Avery R; Mossad SB
Transpl Int; 2013 Aug; 26(8):822-32. PubMed ID: 23763289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
